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AbstrACt
Introduction Inspections are widely used in health care 
as a means to improve the health services delivered 
to patients. Despite their widespread use, there is 
little evidence of their effect. The mechanisms for how 
inspections can promote change are poorly understood. In 
this study, we use a national inspection campaign of sepsis 
detection and initial treatment in hospitals as case to: (1) 
Explore how inspections affect the involved organizations. 
(2) Evaluate what effect external inspections have on the 
process of delivering care to patients, measured by change 
in indicators reflecting how sepsis detection and treatment 
is carried out. (3) Evaluate whether external inspections 
affect patient outcomes, measured as change in the 30-
day mortality rate and length of hospital stay.
Methods and analysis The intervention that we study 
is inspections of sepsis detection and treatment in 
hospitals. The intervention will be rolled out sequentially 
during 12 months to 24 hospitals. Our effect measures 
are change on indicators related to the detection and 
treatment of sepsis, the 30-day mortality rate and length 
of hospital stay. We collect data from patient records 
at baseline, before the inspections, and at 8 and 14 
months after the inspections. We use logistic regression 
models and linear regression models to compare the 
various effect measurements between the intervention 
and control periods. All the models will include time as 
a covariate to adjust for potential secular changes in the 
effect measurements during the study period. We collect 
qualitative data before and after the inspections, and we 
will conduct a thematic content analysis to explore how 
inspections affect the involved organisations.
Ethics and dissemination The study has obtained 
ethical approval by the Regional Ethics Committee of 
Norway Nord and the Norwegian Data Protection Authority. 
It is registered at www. clinicaltrials. gov (Identifier: 
NCT02747121). Results will be reported in international 
peer-reviewed journals.
trial registration NCT02747121; Pre-results.
IntroduCtIon
External inspections constitute a core compo-
nent of regulatory regimes and certification 
and accreditation processes.1 2 Different 
terms such as external review, supervision 
and audit have been used to describe this 
activity.3 4 There are differences between 
these approaches, but they have in common 
that a healthcare organisation’s perfor-
mance is assessed according to an externally 
defined standard. We use the term ‘external 
inspection’, which implies that the inspec-
tion is initiated and controlled by an organ-
isation external to the one being inspected.5 
We define external inspection as: a system, 
process or arrangement in which some 
dimensions or characteristics of a healthcare 
provider organisation and its activities are 
assessed or analysed against a framework of 
ideas, knowledge, or measures derived or 
developed outside that organisation.6
Inspections are widely used in healthcare 
as a means to improve the quality of care 
delivered to patients.1 7 Quality of care is a 
complex concept that can be understood 
in different ways.8 We understand quality of 
care as: the degree to which health services 
for individuals and populations increase 
the likelihood of desired health outcomes, 
and are consistent with current professional 
knowledge.9 We found this definition expe-
dient because it highlights that the quality 
of care encompasses outcomes for patients 
and populations, and that the outcomes are 
strengths and limitations of the study
 ► This is a comprehensive study in a field where 
few experimental studies have previously been 
published.
 ► The study has the potential to provide new 
knowledge about the effects of external inspections 
and their mechanisms for change.
 ► Key challenges include possible contamination of 
the control group, lack of documentation in patient 
records and the overall sample size.
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dependent on the delivery of health services consistent 
with current professional knowledge. External inspec-
tions can be used with the intention to secure that 
delivery of health services are consistent with current 
professional knowledge.
Despite the widespread use of external inspections,2 
few robust studies have been undertaken to assess their 
effects on the quality of care.10 The effects of inspections 
remain unclear and the evidence is contradictory.5 11–13 
Observational studies have demonstrated a positive asso-
ciation between accreditation and the ability to promote 
change, professional development, quality systems and 
clinical leadership.11 14 15 Research suggests that there is 
an association between inspections and different quality 
outcomes, for example, reduced incidence of pressure 
ulcer and suicides16–18; however, randomised controlled 
studies have not been able to find evidence of impact of 
inspections on the quality of care.19 20
We suggest that the conflicting evidence can partly be 
explained by the fact that inspection can be considered 
a complex intervention consisting of different elements 
that are introduced into varying organisational contexts.21 
The way the inspection process is conducted will thus 
influence how the inspected organisations implement 
improvements following inspection. The manner in 
which external inspections affect the involved organisa-
tion is currently poorly understood.5 22–24 We need more 
knowledge about the effects of inspections as well as a 
better understanding of the mechanisms for how they can 
contribute to improving quality of care.5 11 Such knowl-
edge can deepen our understanding of why the effects of 
external inspections seem to vary, which in turn can facil-
itate the development of more effective ways to conduct 
inspections.5
In this study, we use external inspections related to 
sepsis detection and treatment in hospitals to explore 
how such inspections affect the involved organisations 
and to evaluate their effect on the quality of care. Sepsis 
is a prevalent disease and one of the main causes of 
death among hospitalised patients internationally and in 
Norway.25 26 Early treatment with antibiotics and improved 
compliance with treatment guidelines are associated with 
reduced mortality among patients with sepsis.27–30 Inter-
national studies have shown that compliance with treat-
ment guidelines varies, and that increased compliance 
can improve patient outcomes.27 28 31 32 External inspec-
tions of Norwegian hospitals have demonstrated that 
insufficient governance of clinical processes in the emer-
gency room could have severe consequences for patients 
admitted to the hospital with undiagnosed sepsis.33 On this 
background, the Norwegian Board of Health Supervision 
decided to conduct a nationwide inspection campaign of 
sepsis detection and treatment in acute care hospitals in 
Norway during 2016–2017 as part of its regular inspec-
tion activities. Moreover, the Norwegian Board of Health 
Supervision also decided to conduct the present scientific 




The study has three main objectives:
1. To explore how inspections affect the involved 
organisations;
2. To evaluate what effect external inspections have on 
the process of delivering care to patients with sepsis, 
measured by change in key indicators reflecting how 
sepsis detection and treatment is carried out;
3. To evaluate whether external inspections affect 
patient outcomes, measured as change in the 30-day 
mortality rate and length of hospital stay for patients 
with sepsis.
Conceptual framework
We take the perspective that quality of care can be consid-
ered a system property that is dependent on how the organ-
isation providing care performs as a whole.34 Improving 
the quality of care is thus dependent on changing organ-
isational behaviour, which implies changing the way clini-
cians interact and perform their clinical processes.35 36 
Change in organisational behaviour is a complex social 
process that involves a range of different organisa-
tional activities.37 If external inspection is to contribute 
to improvement in the quality of care, it should have 
an impact on those activities involved in organisational 
change, here defined as any modification in organisa-
tional composition, structure or behaviour.38
We have previously conducted a systematic review of 
published research to identify the mechanisms of how 
external inspections can contribute to improving quality 
of care in health organisations.39 By combining empirical 
evidence and theoretical contributions, we found evidence 
to support that external inspections need to affect both 
organisational ideas and organisational change activi-
ties to improve the quality of care. Organisational ideas 
encompass theoretical constructs like organisational 
readiness for change, awareness of current practice and 
performance gaps and organisational acceptance that 
change is necessary.40 41 Organisational change activities 
refer to key activities involved in quality improvement like 
setting goals, planning and implementing improvement 
measures and evaluating effect of such measures.42 43
Figure 1 depicts our overall conceptual framework, 
how the elements of the framework relate to the different 
study aims and the corresponding data and effect 
measures. We suggest that inspections can affect organi-
sational ideas and initiate change activities, which in turn 
can lead to organisational change. We collect qualitative 
data to explore how the inspections affect the involved 
organisations. Moreover, we suggest that organisational 
change and change in the process of detecting and 
treating patients with sepsis can contribute to improve 
the quality of care. To measure change in the process of 
detecting and treating sepsis, we collect data that reflect 
this process, for example, time to triage, time to initial 
assessment by physician and time to treatment with antibi-
otics. We refer to these data as process indicators, because 
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they reflect how the process of detecting and treating 
sepsis is carried out. To measure change in the quality of 
care we use two outcome measures, length of hospital stay 
and 30-day mortality rate.
study design
Randomised controlled trials (RCTs) are considered the 
gold standard for assessing the effects of an interven-
tion.44 However, in the present project, an RCT will not 
be feasible as it is impossible to establish an appropriate 
control group. Data regarding detection and treatment 
of sepsis are not available as routine data in Norway. 
Such data can only be collected by reviewing individual 
patient records. According to Norwegian legislation, the 
inspection teams have access to patient records and can 
collect relevant data as part of the inspection. If we were 
to conduct an RCT, the inspection teams would have 
to collect data from hospitals that were not inspected. 
Collecting such data is a key ingredient of an inspection 
and would itself be an intervention. Furthermore, if the 
data collected from hospitals in the control group were 
indicative of non-compliant behaviour, the inspection 
teams would have to follow-up their findings with those 
hospitals; thus, it would no longer be a control group. A 
stepped-wedge design has been recommended for evalu-
ating intervention effects when it is not feasible to estab-
lish a control group.45 Furthermore, this type of design is 
recommended for evaluating the effect of service delivery 
type interventions where it is not possible to expose the 
whole study population for the intervention simultane-
ously and where implementation takes time.46 In our case, 
the intervention is aimed at changing service delivery for 
patient with sepsis, it is not possible to conduct all inspec-
tion simultaneously, and implementation of change 
following the intervention takes time.
The intervention will be rolled out sequentially during 
12 months to 24 hospitals, with six clusters of four 
geographically close hospitals. Inspections are carried 
out by six regional teams with members from different 
county governors and external clinical experts. Each 
team conducts four inspections in their region, yielding 
24 inspected hospitals. Owing to practical and adminis-
trative implications, and general work planning for the 
involved team members, the four inspections must be 
clustered together and conducted within a limited time 
span. Each regional team is assigned a time slot of about 
7 weeks in which to conduct their inspections; the order of 
these time slots is randomised (random order generated 
by computer). Table 1 illustrates the incomplete stepped-
wedge design used in the study. The design is incomplete 
in that we do not continuously collect data from all the 
included sites, rather we collect data at four different 
time points. The inspections are rolled out successively 
over 1 year. On average, there are two inspections each 
month, though the exact number of inspections each 
month may vary due to practical work planning for the 
inspection teams and the involved hospitals.
To answer our research questions, we also need to 
collect qualitative data. We use focus group interviews to 
collect qualitative data. The phenomenon that we intend 
to study is how external inspections affect organisational 
Figure 1 Conceptual study framework.
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change processes. Organisational change is dependent 
on interaction between individuals and groups in the 
organisation.47 Focus groups enable interaction between 
group members during data collection, thus resem-
bling the phenomenon we wish to study. An inspection 
at a hospital represents one case, and for each case we 
conduct focus group interviews with the inspection team, 
leaders in the inspected hospital and clinicians before 
and after the inspections.
study population and intervention
The intervention studied is external inspections of 24 
acute care hospitals in Norway, addressing early detection 
and treatment of patients admitted with possible sepsis. 
Table 2 presents the key elements of the intervention.
The inspections are conducted by six regional teams 
from the county governors in Norway. The teams consist 
of a minimum of four inspectors. The leader of the team 
has long experience and particular training in doing 
inspections. The team has medical and legal expertise. 
One of the team members is an external medical expert 
who has special expertise on sepsis. The expert works on 
a daily basis in a hospital but has been hired part time by 
the Norwegian Board of Health Supervision to assist the 
inspection teams. The clinical experts do not participate 
in inspections of hospitals where they have their regular 
work.
The county governors are responsible for supervising 
the hospitals in their region. According to Norwegian 
legislation, hospitals are required to inform the county 
governor about serious adverse patient events, and 
the county governor investigates such patient events 
to decide whether the hospital has delivered inappro-
priate care. Furthermore, the county governor handles 
general patient complaints and carries out inspections in 
different areas on a regular basis. Based on these supervi-
sory activities, the county governors possesses knowledge 
about risk and vulnerability at the hospitals in their coun-
ties, for example, high turnover of personnel, lack of key 
competence or financial constraints.
About 40 acute care hospitals in Norway treat patients 
with sepsis. There is large variation in the size of these 
hospitals and the number of patients treated. All 40 
hospitals are eligible for inspection. The standard proce-
dure used by the National Board of Health Supervision 
for conducting nationwide inspections is followed. This 
procedure implies that the regional teams decide which 
hospitals to inspect in their region. The main criterion 
for selecting which hospitals to inspect is hospital size. 
The large hospitals treat more patients, and consequently 
substandard care will affect many patients. Moreover, the 
inspection teams also use their local knowledge about 
specific risks and vulnerability when selecting hospitals 
for inspection.
The inspections have two components, a system audit48 
and two follow-up audits with verification of patient 
records, at 8 and 14 months after the initial system revi-
sion. The system audits are based on the general require-
ments for system-oriented, planned inspections by the 
Norwegian Board of Health Supervision.49 This proce-
dure has its basis in the Internationational Organiza-
tion for Standardization (ISO) procedures for system 
revisions48 and has been developed and adapted to the 
Norwegian context. Inspection consists of four main 
phases: the development of audit criteria, announcement 
of inspection and collection of relevant documentation 
and data, site visit and reporting and follow-up.
The intervention is a statutory inspection. The 
audit criteria are grounded in two main principles of 
Table 2 Key elements of the intervention
Time in months Activity
1 Inspection team announces inspection and requests the hospital to submit information.
2 Inspection team reviews records of patients with sepsis and collect relevant data for the inspection 
criteria. Data are collected for two time periods, baseline (September 2015) and right before the site 
visit.
Inspection team reviews information from hospital and prepares for the site visit.
3 Two-day site visit at the hospital with interviews of key personnel.
At the end of the site visit, the inspection team presents the preliminary findings, and the hospital can 
comment on these preliminary findings.
4–5 The inspection team writes a preliminary report of their findings. The hospital can comment on the 
report.
6 The inspection team sends the final report to the hospital.
Continuously The hospital plans and implements improvement measures.
11 Follow-up audit 8 months after the site visit. The inspection team reviews records of patients with 
sepsis and collect the same data as they did prior to the site visit.
Report on findings from audit.
17 Follow-up audit 14 months after the site visit. The inspection team reviews records of patients with 
sepsis and collect the same data as they did prior to the site visit.
Report on findings from audit
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Norwegian legislation: (1) healthcare services should 
be safe and effective and provided in accordance with 
sound professional practice50 and (2) organisations that 
provide healthcare services are required to have a quality 
management system to ensure that healthcare services 
are provided in accordance with the legal requirements. 
Hospital management is accountable for the quality 
system. In this way, system audits can challenge the quality 
of performance through addressing the managerial-level 
responsibility to ensure good practice by providing an 
expedient organisational framework for delivering sound 
professional practice.
In cooperation with clinical experts on sepsis, the 
Norwegian Board of Health Supervision developed the 
audit criteria for those clinical practices involved in deliv-
ering care for patients with sepsis, as well as audit criteria 
for the quality management systems to ensure such prac-
tice. These audit criteria were based on current inter-
nationally accepted guidelines for sepsis detection and 
treatment31 51 and reflect good clinical practice. The main 
audit criteria are displayed in box 1.
The inspection teams announce inspections 8 weeks 
prior to the site visit by means of a standardised letter, 
which includes a list of documentation that the inspec-
tion teams request of the inspected hospitals (box 2).
Before the site visit, the inspection teams collect rele-
vant data from patient records corresponding with the 
audit criteria and review all information that the hospital 
has submitted. The inspection teams are reinforced with 
extra medical expertise when they review patient records 
and collect the data. The data collection is surveilled by 
the external medical expert and the head of the inspec-
tion team. By analysing these data, the inspectors develop 
an initial risk profile, based on which the subsequent 
on-site audit is planned in detail.
The on-site visit lasts 2 days. The first day begins with a 
meeting for all personnel involved with the inspection, 
in which the purpose of the inspection and methods 
used are explained. Thereafter, the inspection team 
conducts individual interviews with a strategic sample of 
professionals and managers at different organisational 
levels. The interviews typically last from 15 to 60 min, 
depending on the amount of information needed from 
the informant. Around 20 informants are interviewed in 
total. At the end of the visit, the inspection team pres-
ents its key findings and preliminary conclusions to the 
staff and managers who were involved in the inspection. 
The objective of this feedback is to give the hospital 
an opportunity to correct any misunderstandings or 
misinterpretations.
Following the on-site visit, the inspection team writes 
a report, which is a consensus product of the whole 
team. The report presents the findings, the audit criteria 
against which the findings are reviewed and conclusions 
regarding whether the hospital delivers care in accor-
dance with the audit criteria. The findings are based on 
all the collected data including written documents, inter-
views and review of patient records. The report not only 
presents assessment for each individual audit criterion, 
it also presents an overall judgement of the hospital’s 
management system and its overall ability to deliver care 
in accordance with sound professional standards. Those 
findings that support the judgement can thus provide 
important information on why the hospital fails to deliver 
box 1 Main audit criteria
 ► Triage within 15 min of arrival at the hospital.
 ► Assessment by a physician in accordance with time limits specified 
by the triage system.
 ► Blood samples taken within 30 min of arrival.
 ► Vital signs completed within 30 min of arrival.
 ► Blood cultures taken before treatment with antibiotics.
 ► Adequate supplementary investigation to detect the locus of 
infection.
 ► Antibiotic treatment within 60 min of arrival for patients with organ 
dysfunction.
 ► Early antibiotic treatment of patients with sepsis without organ 
dysfunction. There is no definite time limit for this patient 
population, but it is essential that they receive adequate diagnostics 
and observations with no unnecessary delay and early onset of 
treatment when indicated.
 ► Adequate treatment with liquids and oxygen within 60 min of arrival.
 ► Adequate observation of patients while in the emergency 
department.
 ► Adequate discharge of patients from the emergency room for further 
treatment in the hospital (written statement indicating patient 
status, treatment and further actions).
 ► The quality management system should contain updated procedures 
for how the hospital handles all aspects of sepsis detection and 
treatment.
 ► Hospital management must assess to what degree these procedures 
are implemented and followed.
 ► For this, information is required about when patients are actually 
triaged, assessed by a physician and receive appropriate treatment.
box 2 Information requested from hospitals prior to the 
site visit
 ► Information about hospital organisational structure, including 
description of the distribution of authority and responsibility.
 ► Names and job descriptions for all leaders and professional groups 
involved in sepsis treatment.
 ► Relevant written guidelines and procedures regarding sepsis 
detection and treatment.
 ► Quality goals and performance measurements for treatment of 
sepsis.
 ► Internal audits or other reports regarding sepsis detection and 
treatment.
 ► Information about relevant patient complaints and how these have 
been followed up.
 ► Information about relevant internal discrepancy reports and how 
these have been followed up.
 ► Overview of all educational procedures and activities related to the 
topic of the inspection.
 ► Additional information that the hospital feels may be relevant.
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care in accordance with sound professional standards and 
what the hospital can do to improve care.
If the inspection reveals non-compliant performance, 
hospital management is responsible for planning and 
implementing necessary improvements. The inspection 
teams follow-up the hospitals to confirm that necessary 
changes have been implemented and that the changes 
in fact improve clinical care. At 8 and 14 months after 
the inspections, the inspection teams conduct a follow-up 
audit where they review patient records and collect the 
same data that they collected prior to the inspection. 
These data provide insight into how the diagnostic and 
treatment processes for patients with sepsis are carried 
out, and is used to judge whether the hospital has 
managed to improve sepsis detection and treatment. 
Following the audits at 8 and 14 months, the inspection 
teams write a short report summarising the initial findings 
of the inspection, what the hospital has done to improve 
their performance and the findings from the audit.
To reduce variation in the delivery of inspections, the 
Norwegian Board of Health Supervision has developed a 
common framework standardising intervention delivery. 
All audit criteria and the way in which these should be 
measured are operationalised and described, and a 
detailed description of how the inspection teams should 
carry out the inspections is provided. Such a frame-
work can contribute to harmonisation of the inspection 
teams with regard to the way in which key activities are 
performed.52 The inspection teams also receive training 
and exchange experiences to harmonise the way in which 
they deliver the intervention.
data collection
Quantitative data
Figure 2 outlines the clusters and the data collection. For 
each inspection, we collect data at four different time 
points, referred to as P0, P1, P2 and P3. P0 is the base-
line measurement for all hospitals before the Norwegian 
Board of Health Supervision announced the inspection 
campaign. The campaign is part of the regular planned 
inspection activities. These activities are transparent 
for the hospitals and are announced in advance, in this 
particular case 6 months before the first inspection. Due 
to practical reasons, the inspection teams collect data 
for P0 and P1 at the same time right before the inspec-
tion. Data for P0 are thus collected retrospectively, but it 
is predefined that the patients that will be included are 
the last patients with suspected sepsis that were admitted 
prior to 1 October 2015.
Data for P0 are collected from the time period right 
before the inspection campaign was announced. All 
hospitals know that they can be inspected. By collecting 
data before the campaign was announced, we can track 
changes throughout the inspection cycle and assess to 
what extent changes are implemented before the inspec-
tions are undertaken. P1 is the preinspection measure-
ment and P2 and P3 are post-inspection measurements. 
The regional inspection teams collect data during the 
inspection and audits conducted 8 (P2) and 14 months 
(P3) following the initial inspection. These data serve 
two purposes. They are used to guide the judgements on 
whether the inspected hospitals comply with the require-
ments and to evaluate how inspections affect the clinical 
processes involved in diagnosing and treating sepsis.
We use a two-step approach to identify eligible patients 
who might have sepsis on arrival at the hospital. First, a 
record search of the National Patient Register (NPR) is 
carried out, using diagnostic codes for infections and 
sepsis. The NPR is a national common register of all 
patients and the treatment they have received in Norwe-
gian hospitals. This record search will produce a list of 
patients with an identification number that will enable 
the inspection teams to access the corresponding patient 
records at inspected hospitals. Second, the inspection 
teams assess the individual patient records for eligibility. 
Figure 2 Illustration of clusters and data collection.
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The inclusion criteria are clinically suspected infec-
tion and at least two systemic inflammatory response 
syndrome (SIRS) events, excluding elevated leucocytes.53 
The inspection teams extract data from the included 
patient records.
Based on the literature, previous research and discus-
sion with clinical experts, we identified relevant effect 
measures that reflect how hospitals handle patients 
admitted to the hospital with suspected sepsis.28 54 These 
indicators are displayed in box 3. In addition, data are 
collected for the following control variables: patient sex 
and age, sepsis with organ dysfunction and hospital size.
We use 30-day mortality rate as our key outcome measure, 
defined as the ratio of patients with sepsis who are dead 
within 30 days of hospital admittance. Mortality measures 
based on in-hospital deaths alone, can be misleading 
as indicators of hospital performance.55 Our measure 
also includes out-of-hospital deaths. Using the unique 
personal identification number provided to all citizens of 
Norway, we are able to link the patient record data with 
data from the National Registry to calculate the 30-day 
mortality rate. Thirty-day mortality rate is an established, 
national quality indicator for Norwegian hospitals,56 and 
this indicator has been shown to have better validity as a 
hospital performance measure than in-hospital mortality 
for selected medical conditions.57 Thirty-day mortality 
rate has also previously been used to assess effects of 
measures to improve care for patients with sepsis.58
We consider the percentage of patients with organ 
dysfunction who have received antibiotic treatment within 
1 hour as the key measure, because it is associated with 
our outcome measure, 30-day mortality rate.27 28 Further-
more, we suggest that early triage and early assessment 
by medical doctor are key activities to secure timely treat-
ment with antibiotics and that the corresponding process 
measures consequently are important too.
The power calculations were performed using the 
stepped-wedge function in Stata/IC V.14.0 (StataCorp 
LLC) software for Windows, developed by Hemming and 
Girling.59 The statistical power in a stepped-wedge design 
depends on the total number of intervention sites, the 
total number of data collection points for each interven-
tion site, the number of patient records included at each 
data collection point, the correlation between clustered 
observations on the same hospital (intracluster correla-
tion) and the implementation period.45 We based our 
calculations on 24 intervention sites, 4 data collection 
points and 33 patient records per collection point at 
each intervention site. As the intracluster correlation may 
vary between samples and between process and outcome 
measurements, it is not straightforward to specify an intra-
cluster correlation in advanced. In addition, we could not 
find any estimated intracluster correlation in previous 
trials of patients with sepsis. Consequently, we chose 
an intracluster correlation of 0.05, which is in line with 
that estimated for several patient outcomes in a cluster 
randomised trials of heart failure patients.60 Type I and 
II errors were assumed to be 0.05 and 0.20, respectively.
Because assessment of patient records must be done 
manually, data collection is resource demanding. Thus, 
box 3 Effect measures
Process measures
 ► Percentage of patients who have been triaged within 15 min of 
arrival in the emergency room.
 ► Percentage of patients who have been assessed by a medical doctor 
within the time frame set during triage.
 ► Percentage of patients in which vital signs have been evaluated 
within 30 min.
 ► Percentage of patients in which blood lactate has been measured 
within 30 min.
 ► Percentage of patients from which supplementary blood samples 
have been taken within 30 min.
 ► Percentage of patients from which a blood culture is taken prior to 
administration of antibiotics.
 ► Percentage of patients in which adequate supplementary 
investigation to detect locus of infection has been undertaken within 
24 hours.
 ► Percentage of patients who have received antibiotics treatment 
within 1 hour of arrival in the emergency room.
 ► Percentage of patients who have received intravenous fluids within 
30 min.
 ► Percentage of patients who have received oxygen therapy within 
30 min.
 ► Percentage of patients for whom an adequate surveillance regime 
has been established.
 ► Percentage of patients who have been adequately discharged from 
the emergency room for further treatment in the hospital (written 
statement indicating patient status, treatment and further actions).
outcome measures
 ► Hospital length of stay.
 ► 30-day mortality rate.
box 4 Key research questions of the qualitative study
 ► How do inspection teams plan, conduct, follow-up, and finalise the 
inspections?
 ► How do the inspected organisations prepare for inspections?
 ► Do inspections contribute to creating awareness about current 
performance and possible performance gaps in the clinical system 
for delivering care to patients with sepsis?
 ► Do inspections contribute to engaging leaders and clinicians in 
improvement of their work?
 ► Do hospitals initiate improvement activities aimed at enhancing the 
quality of sepsis care prior to inspections?
 ► Do inspections affect organisational ideas, for example, 
understanding of the clinical system and commitment to change?
 ► Do clinicians and leaders reflect on the performance of their clinical 
system before and after the inspections?
 ► What kind of change activities do hospitals initiate following the 
inspections, and how do these affect the quality of care delivered 
to patients with sepsis?
 ► What is the impact of other contextual factors on the improvement 
process?
 ► How do follow-up audits of patient records affect the change 
processes?
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we must balance the design and power of the study against 
the available resources, a manageable amount of data 
collection and likely detectable changes in the key effect 
measures. For the process data, we have powered the 
study according to the key clinical process indicator, anti-
biotic treatment within 1 hour of arrival at the hospital. To 
detect an absolute improvement of 15 percentage points, 
for example, from 50% to 65% of patients receive antibi-
otic treatment within 1 hour of arrival, we must include a 
minimum of 2376 patient records. We intend to include 
n=3168 patients (24 hospitals×4 time points×33 patients); 
we assert that this sample is large enough to examine the 
other relevant process indicators described in box 3.
To reach sufficient statistical power to detect a signif-
icant change in patient outcome measures, such as 
30-day mortality rate, we need to include more than the 
33 patients that we include to detect changes in process 
measures per each time point. We have powered the 
study to detect a reduction from 15% to 11.5% in the 
mortality rate by including 60 patients for each hospital at 
each time point. The total intended number of included 
patients for outcome measures is n=5760 patients (24 
hospitals×4 time points×60 patients).
Qualitative data
We conduct focus group interviews based on an interview 
guide. We developed the interview guide based on theory 
about practices involved in implementing organisational 
change61 along with our model for how inspections can 
contribute to improving quality of care by affecting organ-
isational change activities and ideas.39 The key research 
questions that will be further explored in the qualitative 
study are displayed in box 4.
We intend to include a strategic sample of six cases; we 
assert that such a data sample can provide sufficiently rich 
data about the phenomenon we intend to study.62
data monitoring
The external medical expert, together with the leader 
of the inspection team, oversees the data collection 
process. Inspectors with medical expertise collect data by 
reviewing electronic patient records. To increase inter-
rater reliability, the inspectors work in pairs, and they all 
sit together in the same room and can ask for supervi-
sion from the external medical expert when needed. To 
reduce inter-rater bias between the inspection teams, the 
Norwegian Board of Health Supervision has developed 
a framework describing in detail the data that should be 
collected from the patient records and the criteria for 
judgement. All inspection teams have received special 
training and participated in meetings where the audit 
criteria have been discussed to promote a common under-
standing. Once a team is assigned to one hospital, they 
collect data at all four time points. To promote validity 
and reliability of the collected data the involved hospi-
tals can oversee how data are collected. The entire data 
collection process is transparent for the inspected hospi-
tals, and the hospitals can verify all the collected data if 
they wish. The complete data file is checked manually 
before analysis, and we also apply various procedures of 
electronic field checks to secure data quality.
data analysis
Statistical analysis
Descriptive statistics will be used to quantify sample char-
acteristics. All analysis will use patient-level data, collected 
at four periods for different patients for 24 hospitals—
two collections during the control period and two collec-
tions during the intervention period for each hospital. 
To compare the various process and outcome measure-
ments (dependent variables) between the intervention 
and control periods (independent variable), we will 
use logistic regression models for binary measurements 
and linear regression models for continuous measure-
ments. The choices of regression methods for the various 
measurements are outlined in table 3. As recommended 
in the literature,63 64 all models will include time as a 
covariate to adjust for potential secular changes in the 
process and outcome measurements during the study 
period. The underlying form of time will be included in 
the models as a linear term, polynomial term or cubic 
spline term, as appropriate.
Norway is divided into 18 counties in addition to its 
capital city, and there are acute hospitals that treat patients 
with sepsis in all counties. The population density varies 
between the counties. The smallest acute hospitals serve a 
population of about 50 000, while the largest serve a popu-
lation of about 500 000. The sizes of the intensive care 
units and the number of patients with sepsis treated 
during a year will therefore differ between the included 
hospitals. This is a national inspection campaign, and 
hospital in all counties will be inspected. As patients are 
sampled from different hospitals, a between-hospital vari-
ation in measurements is likely, introducing correlated 
data within the hospitals. To account for this intracluster 
correlation, we will use generalised estimating equations 
methodology,65 specifying an exchangeable working 
correlation structure, that is, any two patients are equally 
correlated within hospitals regardless of time and inter-
vention and control periods. However, as this assumption 
might not hold for all hospitals, a method for obtaining 
cluster-robust standard errors of model parameters will 
be applied.66 Finally, as our repeated sampling of patients 
with sepsis may not be entirely representative of the total 
population, difference in certain patient characteristics, 
including age and sex, between comparison periods 
might arise. In that case, the above-mentioned models 
will also include such covariates for obtaining correct 
model means.
Qualitative analysis
The focus group interviews will be taped and transcribed. 
We will perform a thematic content analysis of the data 
guided by theory and the data themselves.67 The quantita-
tive data will indicate whether the clinical processes have 
improved. The focus for the analysis of the qualitative 
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data is to understand more about why and how the clin-
ical processes for detecting and treating sepsis have been 
changed or not changed.
We have developed a theory of change for the delivery 
of the intervention, which guides our analysis. We used 
the findings from our systematic review as a starting point 
for developing the theory of change for the delivery of the 
intervention. Early detection and treatment of sepsis can 
be challenging because sepsis is a syndrome more than 
a disease,68 and best practice care for this patient group 
consists of a series of time-critical events that can involve 
a range of different actors. Consistently delivering best 
practice care to all patients with sepsis thus relies on a 
well-functioning clinical chain. It can be demanding for a 
hospital to gather relevant data to systematically monitor 
how well the clinical system actually performs over time.69 
Identifying possible performance gaps in the clinical 
system is a key driver for improvement,70 and we planned 
and designed the inspections accordingly.
A key part of the intervention is to assess the design 
of the hospital’s clinical system for delivering care to 
patients with sepsis and to assess how the clinical system 
performs over time. As part of the inspection, the inspec-
tion teams collect data that reflect the key elements of 
providing best practice care for patients with sepsis. The 
inspection teams emphasise presentation of these data in 
an easily comprehensible way using graphs and diagrams. 
Furthermore, they compile and aggregate quantitative 
data together with interview data from the inspections to 
provide a better understanding of shortcomings in the 
clinical system and its interdependencies. We suggest that 
a thorough assessment of the clinical system for delivering 
care to patients with sepsis can contribute to enhancing 
leaders’ and clinicians’ understanding of their current 
performance and to raise their awareness regarding 
possible performance gaps of which they were previously 
unaware. A better understanding of their current prac-
tices and possible performance gaps can thus trigger 
further reflection on performance. We suggest that such 
reflection can in turn contribute to a shared commitment 
to address shortcomings in the clinical system by plan-
ning, implementing and evaluating expedient measures 
to address performance gaps. Through the analysis of 
the qualitative data, we explore whether inspections have 
affected organisational ideas and change activities in line 
with our suggest theory of change.
During the postintervention interviews, we assess 
compliance with delivery of the key components of the 
intervention, as a way of determining to which extent 
the inspection teams have performed the inspections in 
accordance with guidelines and requirements. The key 
components for which we assess compliance are displayed 
in box 5.
strEngths, PotEntIAl lIMItAtIons And bIAsEs
Regulatory measures within healthcare seem to be 
increasing, and the burden and effect of such measures 
are being questioned.69 71 Previous studies have evalu-
ated different approaches to regulation and surveillance 
in healthcare, but we have limited knowledge about the 
actual effect of such measures on the quality of care.72 73 
External inspections are core components of regulatory 
regimes and are frequently used within healthcare.1 2 It is 
therefore of importance to gather more knowledge about 
the effects of this regulatory measure and how inspec-
tions might contribute to improving healthcare quality. 
Few studies have used an experimental design to assess 
Table 3 Outline of regression models for the various process and outcome measurements
Indicator Dependent variable Type GEE model*
Process Triage within 15 min Binary Logistic regression
Process Timely assessment by physician Binary Logistic regression
Process Vital signs evaluated within 30 min Binary Logistic regression
Process Blood lactate measured within 30 min Binary Logistic regression
Process Supplementing blood samples within 30 min Binary Logistic regression
Process Blood culture taken before antibiotics Binary Logistic regression
Process Adequate supplementing investigation within 24 hours Binary Logistic regression
Process Antibiotic treatment within 1 hour Binary Logistic regression
Process Intravenous fluid within 30 min Binary Logistic regression
Process Oxygen therapy within 30 min Binary Logistic regression
Process Adequate surveillance regime established Binary Logistic regression
Process Adequate discharge from emergency room Binary Logistic regression
Outcome 30 day mortality Binary Logistic regression
Outcome Length of stay Continuous† Linear regression
*Regression models with GEE.
†Transformed if skewed distribution.
GEE, generalised estimating methodology.
group.bmj.com on September 6, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 11Hovlid E, et al. BMJ Open 2017;7:e016213. doi:10.1136/bmjopen-2017-016213
Open Access
the effects of external inspections.10 We suggest that the 
reason for this is that external inspections represent 
contemporary events involving a whole range of auton-
omous actors in society, which makes it challenging to 
apply an experimental design. In our case, it involves the 
Norwegian Board of Health Supervision, 18 autonomous 
county governors, 24 hospitals and the NPR. The main 
strength of our study is the fact that we have been able to 
persuade all involved actors to cooperate and commit to 
conducting the inspections using a stepped-wedge design.
The stepped-wedge design enables us to track changes 
in outcome measures for sepsis detection and treatment 
over time. The changes that we might observe in the 
outcome measures are not necessarily attributable to the 
inspections alone. There can be other factors beside the 
inspections that can affect sepsis detection and treatment 
during the study period. Our qualitative data can help 
identifying such factors and provide insight into how they 
might interact with the inspections. By combining find-
ings from the qualitative and quantitative data, we assert 
that we can assess how sepsis detection and treatment 
develops over time and substantiate how inspections 
along with other factors can affect the development.
Our study is based on an overall framework suggesting 
that the inspections need to affect organisational ideas and 
activities to facilitate change in organisational behaviour 
and thereby improve quality of care for patients with 
sepsis (figure 1). Moreover, we have developed a more 
detailed theory of change for the inspections, suggesting 
how they can contribute to affect organisational change. 
We collect quantitative data that indicate whether organ-
isational behaviour and the quality of care improve after 
the inspections. By combining these findings with our 
qualitative data that provide insight into how the inspec-
tions affect organisational change, we can test our theo-
ries about how inspections can contribute to improve the 
quality of care. We suggest that our study can contribute 
to build theory about how inspections can improve the 
quality of care and thus have relevance for inspections 
covering other topics.
Initially, we had intended to use data from the NPR to 
calculate the 30-day mortality rate and hospital length 
of stay. After we had begun planning our study and had 
received ethical approval, a new definition for sepsis and 
septic shock was issued.74 Patients with sepsis are identi-
fied in the NPR using diagnosis codes of the International 
Classification of Diseases, 10th revision. Previous research 
has shown that coding practice for sepsis varies between 
hospitals and can change over time.75 76 We assert that the 
new sepsis definition will affect how Norwegian hospitals 
code sepsis; therefore, we cannot use available routine 
data to calculate our outcome measures. Instead, we must 
use a more labour-intensive approach and manually scan 
all patient records that we include.
Though more time consuming, including patients 
based on manual reviews of patient records, instead of 
sepsis codes, is strengthening our study. The patients 
in this study are recruited from a population identified 
through a standardised search in the NPR that includes 
sepsis codes and the most commonly used infection codes. 
Patients are included based on SIRS criteria. We assert 
that a change in coding practice owing to the new sepsis 
definition will not alter the patient population identified 
by our standardised search. The new sepsis definition is 
narrower; it is therefore likely that fewer patients will be 
coded with sepsis. Patients that do not fulfil the criteria 
for sepsis under the new definition will still be assigned an 
infection code and will therefore be encompassed in the 
patient population identified by our standardised search.
The inspections in our study are contemporary and 
transparent events, thus it is not possible to mask who is 
exposed to the intervention. Nor is it possible to mask 
the data collection. Because there is no available routine 
date about sepsis detection and treatment, such data are 
collected as part of the intervention in our study. The 
inspections teams access the patient records manually, 
and they will therefore know which hospital the patients 
belong to and whether the patient was admitted before or 
after the inspection. The fact that data are collected as part 
of the intervention can be viewed as a limitation. Doing 
data collection during the inspection is however standard 
procedure, and thus not atypical for the inspections in 
our study.48 Given the nature of the intervention—that is 
collecting data, reporting and giving recommendations—
what we are in fact measuring is, at least in part, the effect 
of data collection.
To enhance data quality and reduce bias, the Norwegian 
Board of Health Supervision has developed a framework 
and detailed criteria on which data collection is based. 
Moreover, data collection is done by experienced inspec-
tors with particular medical expertise, and the whole 
process is overseen by the external medical experts and 
the leaders of the inspection teams. The data collection 
is transparent for the inspected hospital. They can verify 
all the collected data and give feedback if they encounter 
missing data or data that has been misinterpreted.
The patients included in this study have a suspected 
serious infection that potentially requires rapid treatment. 
The process data that we collect addresses sepsis detec-
tion and treatment in the initial phase of the hospital stay, 
box 5 Key components of the intervention, which are 
assessed for fidelity
 ► Initial letter announcing the inspection and requesting documentation 
from hospitals.
 ► Review of documentation from hospitals prior to site visit.
 ► Patient record review prior to site visit.
 ► Start-up meeting at site visit.
 ► Interviews with physicians, managers and nurses during site visit.
 ► Closing meeting at site visit.
 ► Written report following site visit containing judgement of clinical 
performance based on quantitative process data from patient 
records and interview data.
 ► Audit of patient records 8 months after site visit.
 ► Audit of patient records 14 months after site visit.
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for example, the time to triage, assessment by a physician 
and antibiotics treatment. Such process measures are still 
relevant for the patient population included in our study, 
regardless of whether they fulfil the criteria for sepsis 
using the new definition. Because our main objective is 
to track changes over time in the quality of care delivered 
to a defined patient population, we assert that our study 
design and process data are still valid and relevant despite 
the introduction of a new definition of sepsis.
We had to balance the power of the study against the 
available resources and a manageable amount of data 
collection. We designed and powered the study to detect 
realistic changes in our outcome and process measures. 
However, there is an inherent risk that the study can 
become underpowered to detect changes in our effect 
measures. A potential challenge is information missing 
in the patient records. Lack of documentation itself can 
be an important finding because this can be associated 
with poorer patient outcomes.77 If information regarding 
process measures is missing in the patient records, it 
will affect the power of the study, which can potentially 
become underpowered. If there is an association between 
substandard care and lack of documentation in the patient 
records, our preinspection data may be biased. Poor care 
will only be indicated by missing data but will not be 
supported by actual empirical data. Following inspection, 
it may be easier to improve the documentation practice 
within a hospital than actually improving the delivery of 
care. Thus, there is a risk that the postintervention data 
will be biased because they include substandard care that 
would not have been documented prior to inspection.
Postinspection data are collected 8 and 14 months after 
inspection. There is a delay of about 2 months after the 
on-site visit before the hospitals receive their final report. 
Implementing true change in a clinical system can be 
time consuming. To give the hospital time to plan and 
implement changes, we schedule the first follow-up audit 
8 months after the initial site visit. We assert that the 
hospitals have begun to implement change at this point. 
The feedback after the first audit will not be as extensive 
as that in the report following the site visit, and the feed-
back will be provided to hospitals without much delay. 
The hospitals can use this feedback to adapt and reit-
erate their ongoing improvement activities. We therefore 
schedule the second follow-up audit 6 months after the 
first.
A likely challenge in our study is possible contamina-
tion of the control group, that is, hospitals that have not 
yet received the intervention. All hospitals in Norway are 
aware of the nationwide inspection campaign on sepsis 
treatment now that the inspections are under way. There is 
a possibility that hospitals that have not yet been inspected 
will begin to make improvements prior to inspection. We 
therefore collect data at P0 to obtain a baseline measure-
ment for all hospitals before announcing the inspection 
campaign. Collecting quantitative data from P0, P1, P2 
and P3 as well as qualitative data will enable investiga-
tion of the extent to which hospitals implement changes 
before the inspections and explore how change processes 
unfold in the inspected hospitals.
Factors like socioeconomic status and comorbidity 
can affect the outcomes. We do not have access to such 
data and can therefore not adjust for these factors. In a 
stepped-wedge design, all sites are exposed for the inter-
vention and we compare change in the effect measures 
before and after the intervention. We collect the data 
in a standardised way, and the intervention itself should 
not affect which patients that are admitted to the hospi-
tals. Consequently, we have no reason to believe that 
confounding factors should be unevenly distributed in 
the study population before and after the intervention.
The size of the included hospitals differ. The order 
of the inspections are randomised in clusters of four 
hospitals, and all the clusters include hospitals with 
different sizes. To account for intracluster correlation, 
we will use generalised estimating equations method-
ology,65 and we will include hospital size as a covariate 
in our analytic models. Due to Norwegian topography 
with long travel distances, patients with suspected sepsis 
are typically sent to the nearest acute hospital for initial 
diagnosis and treatment. In some cases, patients with 
septic shock can be transferred to a larger hospital later. 
We know the number of patients with organ dysfunc-
tion admitted to the various hospitals and can adjust for 
this in our analysis. We do however not have access to 
data about comorbidity for the included patients and 
can therefore not fully adjust for case mix differences 
between the included hospitals. Our process measures 
cover the initial steps of the diagnostic and treatment 
process, which is done in all hospitals irrespectively of 
size. We compare changes in the effect measures before 
and after the intervention, and the intervention itself 
should not affect which patients that are admitted 
to the different hospitals. Consequently, we have no 
reason to believe that case mix differences between the 
inspected hospitals should change before and after the 
intervention.
External inspections can have intended and unin-
tended outcomes.78 The aim of our study is to assess the 
effects of inspection on the intended outcome, that is, 
improved care for patients admitted to the hospital with 
suspected sepsis. However, there can be intended and 
unintended outcomes of inspections that this study does 
not explicitly address. One such intended outcome is to 
create legal safeguarding. Governmental or other public 
institutions often perform external inspections as one 
of many measures within a larger regulatory system that 
aims to ensure delivery of services according to certain 
requirements. An independent system of external control 
can contribute to confidence that certain services meet 
relevant quality requirements, both for the recipients of 
said services and for the public in general. By having an 
independent controlling mechanism, patients need not 
examine and control the safety and quality of services 
themselves.79 Inspections can thus be regarded as a 
means of legally safeguarding users and the public. This 
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is an intangible outcome that is difficult to quantify and 
evaluate, and it will not be addressed in our study.
Another outcome that we only partially address is 
the possibility of goal displacement. Whatever is being 
inspected tends to receive attention.80 81 An unintended 
effect of inspections can therefore be that members of 
the inspected organisation become so preoccupied with 
responding to an ongoing inspection that they neglect 
more important improvement efforts initiated by the 
organisation itself. Furthermore, inspections can influ-
ence how the organisation prioritises its resources,22 81 82 
and there is an inherent danger that the inspection 
can draw resources away from areas in greater need of 
resources. Our qualitative data can provide insight into 
these unintended consequences of inspection to some 
extent, but we will not be able to quantify these effects.
A basic precondition for external inspections is that the 
inspected organisation is accountable for implementing 
necessary changes following an inspection. The effect of 
an inspection thus depends on delivery of the inspection 
and the inspected organisation’s capacity to implement 
change.11 83 The latter is in turn dependent on a range of 
factors, for example, engagement by leaders and workers, 
organisational culture, available resources and knowledge 
improvement.42 84 85 We assert that the outcome measures 
used in this study reflect both the inspection delivery and 
the improvement capacity of the inspected organisation. 
Delivery of the inspection cannot be evaluated in isolation 
from the inspected organisation’s ability to effect change. 
Still, we argue that a lack of improvement following an 
inspection can primarily be caused by the inspected organi-
sation’s lack of capacity to implement change and not by the 
inspection itself. Our qualitative data can provide insight 
into the impact of inspection on the organisation and the 
organisation’s capacity to implement change. To a certain 
extent, we can therefore interpret the absence of change 
as either being primarily a consequence of weaknesses in 
the delivery of inspection or owing to the inspected organ-
isation lacking the capacity for improvement. However, 
one limitation of our study is that we cannot quantitatively 
distinguish between these two causes.
There is a striking mismatch between the widespread 
use of external inspections in healthcare and the paucity 
of evidence of their effect.10 We combine quantitative and 
qualitative data in an innovative way that can contribute 
to shed light on how inspections affect the quality of care 
delivered to patients with sepsis. Despite the limitation 
of our study, we argue that it is robust enough to provide 
new and needed knowledge about the effects of external 
inspections.
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